
    
      Indeed, use of simvastatin might attenuate liver fibrosis in patients with chronic C
      infection, it may also reduce hepatic vascular resistance and portal pressure by improving
      liver generation of nitric oxide and hepatic endothelial dysfunction in patients with
      cirrhosis, so it could be an effective therapy for portal hypertension. It might even improve
      survival of patients with cirrhosis after variceal bleeding.
    
  